Nagaraj Kulkarni

Employment

• Sravathi AI Technology Pvt Ltd Chief Scientist
  2020 - Present
• Liveon Biolabs Pvt Ltd Head
  2018 - 2020
• University of Gothenburg Visiting Researcher
  2017 - 2018
• Hetero Drugs Scientist
  2014 - 2017
• Orchid Chemicals and Pharmaceuticals Limited Research Associate
  2009 - 2014
• Dr Reddy's Laboratories Ltd Jr. Scientist
  2007 - 2009

Education

• SASTRA University PhD
  2011 - 2016
• Rajiv Gandhi University of Health Sciences M. Pharm (Pharmacology)
  2004 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design.
  ACS omega 2025 DOI: 10.1021/acsomega.4c08049
  +Save
• PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC Design.
  ACS omega 2024 DOI: 10.1021/acsomega.3c07318
  +Save
• STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes.
  Hepatology communications 2021 DOI: 10.1002/hep4.1702
  +Save
• Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease
  JCI Insight 2020 DOI: 10.1172/jci.insight.140483
  +Save
• Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 DOI: 10.1096/fj.201900356rr
  +Save
• Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
  Cellular and Molecular Gastroenterology and Hepatology 2019 DOI: 10.1016/j.jcmgh.2018.12.004
  +Save
• STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue
  Journal of Endocrinology 2018 DOI: 10.1530/JOE-18-0182
  +Save
• Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenografts
  Anti-Cancer Drugs 2017 DOI: 10.1097/CAD.0000000000000544
  +Save
• Metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and psoriasis
  Liver Disease: Diagnosis, Treatment and Management 2016
  +Save
• Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease
  Drug Metabolism and Personalized Therapy 2016 DOI: 10.1515/dmpt-2016-0008
  +Save